Studies suggest that targeting lipid metabolism pathways, such as inhibition of fatty acid synthase (FASN) or acyl-CoA synthetase long-chain family member 4 (ACSL4), could promote ICD by increasing lipid peroxidation and enhancing the immunogenicity of tumor cells [68]. This evidence concerns the gene FASN and neoplasm.